SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksJames Halstead Regulatory News (JHD)

Share Price Information for James Halstead (JHD)

Share Price is delayed by 15 minutes
Get Live Data
128.80    4.60 (3.70%)
Bid:
128.20
Ask:
129.60
Spread: 1.40 (1.092%)
Market Cap: £536.34m
JHD Live PriceLast checked at - London Stock Exchange

Intraday James Halstead Share Chart

Update from the CEO

23 Mar 2020 13:00

RNS Number : 2184H
James Halstead PLC
23 March 2020
 

 

23 March 2020

 

JAMES HALSTEAD PLC

Update from Mark Halstead CEO

 

With the status of COVID-19 evolving rapidly, it provides a highly dynamic and challenging scenario for our business to operate within. Our priority is ensuring the safety of our employees, customers, partners and suppliers.

To assist with this, we have put in place appropriate measures to ensure social distancing in the workplace, homeworking where appropriate and effective use of technology to assist in the operational activities of our businesses. We continue to follow the guidance from international and local health authorities around the world in the territories that we operate within.

At this point in time we must make it clear that our businesses are operating as usual and able to meet the needs of our customers. The distribution businesses are well stocked, our factories are operational, our supply chains are robust and with the exception of localised issues we can meet current business requirements. Communication channels across our businesses remain open.

These are exceptional times and as the situation evolves, I will continue to inform where there are material changes to the above. Our business relationships are important to us, should you have any queries please do not hesitate to contact us.

I would like to take this opportunity to thank all our employees who are working hard to ensure we can fulfil our commitments and wish all our partners, employees, customers and suppliers good health in these uncertain times.

The Group's interim results to 31st December 2019 will be issued on 31st March 2020.

 

Enquiries:

 

 

 

James Halstead plc

Tel: 0161 767 2500

Mark Halstead, Chief Executive

 

Gordon Oliver, Finance Director

 

 

 

Hudson Sandler

Tel: 020 7796 4133

Nick Lyon /Nick Moore

 

 

 

Panmure Gordon (Nomad and Joint Broker)

Tel: 020 7886 2500

Dominic Morley

 

 

 

Arden Partners (Joint Broker)

Tel: 020 7614 5900

Richard Johnson

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
UPDPPURAWUPUGPW
Date   Source Headline
9th Apr 20265:32 pmRNSGrant of Options
8th Apr 20265:19 pmRNSHolding(s) in Company
31st Mar 20267:00 amRNSInterim Results
23rd Feb 20264:48 pmRNSPDMR Acquisition of Shares
30th Jan 20263:32 pmRNSShare Buyback - Replacement
30th Jan 20262:44 pmRNSShare Buyback
29th Jan 20267:00 amRNSTrading Update
8th Jan 20268:20 amRNSBlock Listing Six Monthly Return
5th Dec 20251:00 pmRNSResult of AGM
5th Dec 20257:00 amRNSChairman’s Statement to the Annual General Meeting
14th Nov 202512:12 pmRNSDirector/PDMR Shareholding
14th Nov 202512:11 pmRNSDirector/PDMR Shareholding
17th Oct 20257:00 amRNSPosting of Annual Report and Notice of AGM
1st Oct 20257:00 amRNSPreliminary Results
8th Sep 20257:00 amRNSNotice of Preliminary Results
29th Aug 20253:55 pmRNSBLOCK LISTING SIX MONTHLY RETURN
29th Jul 20257:00 amRNSTrading Update
9th Apr 20255:32 pmRNSHolding(s) in Company
7th Apr 202512:25 pmRNSDirector/PDMR Shareholding
27th Mar 20257:00 amRNSInterim Results
6th Mar 202510:41 amRNSNotice of Interim Results - Replacement
6th Mar 20259:00 amRNSNotice of Inteirm Results
6th Mar 20257:00 amRNSNotice of Interim Results
31st Jan 20257:00 amRNSTrading Update and Notice of Results
27th Jan 20255:09 pmRNSDirector/PDMR Shareholding
6th Jan 20253:15 pmRNSBlock Listing Six Monthly Return
6th Dec 20242:09 pmRNSResults of AGM
6th Dec 20247:00 amRNSAGM Statement
18th Oct 20249:20 amRNSPosting of Annual R&A and Notice of AGM
1st Oct 20247:00 amRNSBoard Changes
1st Oct 20247:00 amRNSPreliminary Results
7th Aug 20248:05 amRNSBlock Listing Six Monthly Return
31st Jul 20247:00 amRNSTrading Update
15th Jul 20247:00 amRNSChange of Broker
8th Apr 20244:54 pmRNSPDMR Exercise of Share Options
3rd Apr 20242:00 pmRNSPDMR Acquisition of Shares
28th Mar 202412:00 pmRNSPDMR Grant of Share Options
27th Mar 20247:00 amRNSInterim Results
5th Mar 202412:30 pmRNSAppointment of Senior Independent Director
31st Jan 20247:00 amRNSTrading Update
4th Jan 20244:34 pmRNSBoard Changes
1st Dec 20232:25 pmRNSResults of Annual General Meeting
1st Dec 20237:00 amRNSAGM Statement
17th Nov 202311:13 amRNSPDMR Grant of Share Options
10th Nov 20234:45 pmRNSBlock Listing Six Monthly Return
10th Nov 20234:43 pmRNSBlock Listing Six Monthly Return
13th Oct 202312:00 pmRNSPosting of Annual R&A and Notice of AGM
2nd Oct 20237:00 amRNSPreliminary Results
1st Aug 20237:00 amRNSTrading Update
31st Mar 20231:57 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.